MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Kala Pharmaceuticals Inc

Abierto

0.15 -6.25

Resumen

Variación precio

24h

Actual

Mínimo

0.12

Máximo

0.16

Métricas clave

By Trading Economics

Ingresos

3.6M

-7.6M

Dividendos

By Dow Jones

Próximas Ganancias

6 abr 2026

Kala Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 abr 2026, 22:56 UTC

Noticias de Eventos Importantes

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 abr 2026, 20:50 UTC

Adquisiciones, fusiones, absorciones

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 abr 2026, 23:55 UTC

Charlas de Mercado

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 abr 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 abr 2026, 23:23 UTC

Noticias de Eventos Importantes

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 abr 2026, 23:07 UTC

Ganancias

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 abr 2026, 23:02 UTC

Noticias de Eventos Importantes

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 abr 2026, 22:39 UTC

Ganancias

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 abr 2026, 22:08 UTC

Charlas de Mercado

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 abr 2026, 21:56 UTC

Adquisiciones, fusiones, absorciones

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 abr 2026, 21:31 UTC

Noticias de Eventos Importantes

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

1 abr 2026, 20:38 UTC

Ganancias

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 abr 2026, 20:31 UTC

Adquisiciones, fusiones, absorciones

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 abr 2026, 20:16 UTC

Adquisiciones, fusiones, absorciones

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 abr 2026, 20:16 UTC

Adquisiciones, fusiones, absorciones

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 abr 2026, 20:13 UTC

Adquisiciones, fusiones, absorciones

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 abr 2026, 20:07 UTC

Charlas de Mercado

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 abr 2026, 20:07 UTC

Adquisiciones, fusiones, absorciones

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparación entre iguales

Cambio de precio

Kala Pharmaceuticals Inc previsión

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Beneficio antes de impuestos

Ventas

Gasto por intereses de deuda

Beneficio operativo

$

Acerca de Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat